Rare diseases
Investigational molecules
Locations
Back to France671 clinical trials in Bois-Guillaume, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Phase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis
FranceComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
FranceA study of upadacitinib in adults with erosive mucosal lichen planus and lichen planopilaris.
FranceA study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.
FranceA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
FranceA study of ficerafusp alfa and nivolumab in patients with head and neck cancer who did not respond to platinum-based chemotherapy.
FranceA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
FranceA study to evaluate the use of diroximel fumarate to reduce brain swelling in patients with a stroke caused by bleeding in the brain.
FranceStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
FranceComparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.
FranceA study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on chronic kidney disease treatments and transplant outcomes, including studies of novel medications like baxdrostat and tegoprubart for improving patient care.
Multiple trials evaluating new therapeutic approaches for transplant recipients and CKD patients.
Clinical investigations into treatments for various blood-related conditions, with emphasis on immune thrombocytopenia and thrombotic disorders.
Advanced studies combining established and experimental treatments for better patient outcomes.
Research examining treatment strategies for viral infections and optimization of antibiotic therapy, particularly in elderly populations.
Studies focused on improving treatment protocols and reducing antibiotic overuse.
Investigation of novel therapies for vasculitis and related autoimmune disorders, including targeted biological treatments.
Evaluating new treatment combinations to improve disease management and patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
